Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation-Reference-Cited by-同舟云学术

Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation

Published:2018-05-02 Issue:7 Volume:53 Page:849-856
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Sølund Christina¹²^ORCID,Hallager Sofie¹,Pedersen Martin S.²³⁴,Fahnøe Ulrik²,Ernst Anja⁵,Krarup Henrik B.⁵⁶,Røge Birgit T.⁷,Christensen Peer B.⁸⁹,Laursen Alex L.¹⁰,Gerstoft Jan¹¹¹²,Bélard Erika¹³,Madsen Lone G.¹²¹⁴,Schønning Kristian³¹²,Pedersen Anders G.¹⁵,Bukh Jens¹²,Weis Nina¹¹²,

Affiliation:

1. Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark;

2. Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;

3. Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Denmark;

4. Department of Science and Environment, Roskilde University, Roskilde, Denmark;

5. Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark;

6. Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark;

7. Department of Medicine, Lillebaelt Hospital, Kolding, Denmark;

8. Department of Infectious Diseases, Odense University Hospital, Odense, Denmark;

9. Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark;

10. Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark;

11. Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;

12. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;

13. Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark;

14. Department of Medical Gastroenterology, Zealand University Hospital, Køge, Denmark;

15. DTU Bioinformatics, Technical University of Denmark, Lyngby, Denmark

Funder

Faculty of Health and Medical Sciences, University of Copenhagen

Roskilde University

The Capital Region of Denmark’s Research Foundation

Novo Nordisk Foundation

Danish Research Council

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2018.1467963

Reference39 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study

3. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

4. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control

5. dst.dk. [Internet]. Denmark: Danmarks Statistik; [cited 2017 Feb 20]. Available from: https://www.dst.dk/.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus RNA is 5′-capped with flavin adenine dinucleotide;Nature;2023-07-05

2. High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway;Scandinavian Journal of Gastroenterology;2022-09-05

3. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts;Journal of General Internal Medicine;2022-04-28

4. Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan;Medicina;2022-04-07

5. A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project;BMC Infectious Diseases;2022-03-01